Spinal Modulation, Inc., a Menlo Park, CA-based developer of implantable spinal cord stimulator system, completed a $30m Series D financing.
Investors include Medtronic, DeNovo Ventures, ePlanet/DFJ, InCube Ventures, Johnson & Johnson Development Corporation, Kleiner Perkins Caufield & Byers, MedVenture Associates, and Raffles Venture Partners.
The company intends to use the proceeds to conduct clinical trials both in the United States and abroad and begin commercialization outside the United States in the near future.
Founded by Chairman Mir Imran and led by President and CEO David Wood, Spinal Modulation is a medical device company developing a spinal cord stimulator system designed to provide physicians with an innovative tool for the treatment of chronic pain.
FinSMEs
15/06/2011